Work

Abstract 7780: The first-in-class covalent peroxiredoxin 3 (PRX3) inhibitor RSO-021 modulates immune phenotypes in mesothelioma

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-7780

Authors: Victoria Gibson, Joanna Dzialo, Aida Habibovic, Christopher Landry, Dean Fennell, Brian Cunniff

Institutions: University of Vermont, University of Vermont Medical Center, University of Leicester

Language: English

Topic: Occupational and environmental lung diseases

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148646830

Cites:

Cited by:

Related to: